Aspergillosis is an uncommon neonatal infection, diagnosed with an increasing frequency over the last two decades. We report a premature neonate who developed aspergillosis while receiving amphotericin B and fluconazole for candidiasis. Despite early recognition and diagnosis, the infant died. We review the clinical appearance of Aspergillus species, the distinctions between primary cutaneous aspergillosis and invasive aspergillosis, and advances in diagnosis and treatment.
INTRODUCTION
In the last four decades, the incidence of invasive opportunistic fungal infections has risen dramatically. 1 Morbidity and mortality rates associated with invasive aspergillosis remain high. Neonates are at particular risk because of immature immune function, the frequent and often prolonged use of broad-spectrum antibiotics, and the use of corticosteroids. Although aspergillosis is rare in neonates, it poses a major threat due to high morbidity and mortality rates and ineffective or untested antifungal therapies in this population. [2] [3] [4] [5] Aspergillus species are ubiquitous molds that are easily isolated from the air, soil, decaying vegetation, and dust. The usual portal of entry for Aspergillus is respiratory. However, in hospitalized patients, invasive catheters provide routes of entry leading to cutaneous or invasive aspergillosis. 6 Other portals of entry into the body include venous arm boards, points of contact where adhesive tape or paper tape is used to secure catheters to extremities, abraded skin, wounds, burns, the external ear, the palate, the epiglottis, and the paranasal sinuses. Recently, Anaissie has implicated hospital water supplies to be a major source of nosocomial fungal infection. Factors increasing the risk of nosocomial aspergillosis include neutropenia and broad-spectrum antibiotic therapy that encourages opportunistic fungal colonization of the gastrointestinal tract.
CASE REPORT
This premature neonate was born to a 30-year-old white female at 23 6/7 weeks gestation and weighed 510 gs. The mother's pregnancy was complicated by first trimester bleeding, an incompetent cervix with a failed cerclage, and urinary tract infection at delivery. She received betamethasone 6 days prior to delivery, was on nitrofurantoin for a long-term indwelling urinary catheter, and was given ampicillin/sullbactam for fever during labor. The infant was delivered via cesarean section. The infant had Apgar scores of 1 and 7 at 1 and 5 minutes, respectively. Table 1 outlines the medical problems of this infant.
The infant's initial blood culture grew Escherichia coli and the patient was treated with ampicillin and gentamicin for 7 days, during which time repeat blood cultures remained positive. A lumbar puncture was deferred until DOL #7 because of the infant's instability. During the first week of life, the patient had an elevated percentage of immature white blood cells, thrombocytopenia, and persistent hyperglycemia. Ampicillin was discontinued and treatment with a third-generation cephalosporin was initiated on DOL #7. On DOL #8 Gram-negative rods were reported in the spinal fluid; E. coli was later identified. The blood culture from DOL #8 remained negative. A repeat lumbar puncture was performed on DOL #13, and cerebrospinal fluid culture was negative.
Treatment with amphotericin B was empirically initiated on DOL #7 because the infant's thrombocytopenia was concerning fungal infection. Fluconazole was added when a urine culture from DOL #7 reported positive for Candida albicans on DOL #9. No other cultures from urine or any other sites ever grew Candida. However, thrombocytopenia persisted and worsened, and hypotension recurred on DOL #11 despite several days of negative cultures for bacteria and yeast by that time.
On DOL #12, an abrasion over the right upper quadrant of the abdomen was first noted. There was no history of trauma or probe placement at this site. Within 24 hours the lesion had developed into a necrotic eschar measuring 12 Â 15 mm with surrounding erythema and tenderness to palpation ( Figure 1 ). On DOL #15, biopsies of the lesion were performed. Periodic acid-Schiff and methenamine silver stains revealed abundant septate hyphae, with 451 branching consistent with Aspergillus species (Figure 2 ). Tissue cultures grew Aspergillus flavus. Surface cultures grew one colony of Staphylococcus aureus, and were negative for anaerobes and yeast. After the tissue biopsy revealed septate hyphae consistent with Aspergillus infection, the conventional amphotericin B was changed to a liposomal preparation and dosed at 5 mg/kg per day.
The condition of the infant continued to deteriorate. Recurrent hypotension required volume and dopamine infusions. Chest X-rays taken serially over the hopitalization showed bilateral diffuse opacities. These opacities were felt to represent RDS. Respiratory support was increased. Abdominal examination revealed the liver edge 1-2 cm below the right costal margin with a palpable spleen tip. Purpura was noted over the scalp, shoulders, neck, and chest. Thrombocytopenia was persistent and severe despite repeated platelet transfusions. The prothrombin and partial thromboplastin times were elevated. An abdominal ultrasound and repeat head ultrasound failed to show abscesses. On DOL #19, several new skin lesions appeared along the right chest and back. The new cutaneous lesions, consumptive coagulopathy, and enlarging liver were consistent with a diagnosis of invasive and disseminated aspergillosis. After further discussions with the family, life support was discontinued. A post-mortem magnetic resonance imaging study failed to show abscesses within the lungs, liver, spleen, kidneys, or bowel segments. The family refused an autopsy; therefore, we were unable to confirm the diagnosis of disseminated aspergillosis.
The newborn ICU had been renovated 6 months prior to occurence of this case of cutaneous aspergillosis. The air within the newborn ICU was not Hepa filtered. The hospital epidemiology service failed to isolate Aspergillus from the ventilation ducts, the air within the nursery, or adhesive tape used for the infant. The hospital water supply was not sampled. No further cases of Aspergillus infection were reported from the nursery.
DISCUSSION
Early clinical recognition of Aspergillus infection is critical in the preterm infant. Aspergillosis may initially present to the clinician as a painful and locally destructive lesion. Findlay et al. 9 described five types of aspergillosis of the skin: (1) the solitary necrotizing dermal plaque, (2) a subcutaneous granuloma, (3) a papular eruption with suppurative vegetating or necrobiotic tendencies, (4) erythema, and (5) progressive confluent granulomas. In primary cutaneous aspergillosis, the typical skin lesion is an erythematous or violaceous papule that progresses to a central ulceration with black eschar within 24 hours. 10 The hemorrhagic bulla of cutaneous aspergillosis may be mistaken for bullous impetigo caused by Staphylococcus aureus, echthyma gangrenosum secondary to Pseudomonas, thermal burns from CO 2 probe placement (Figure 3) , or cutaneous anthrax. 11 Groll et al. 12 detailed clinical presentations of newborns with primary cutaneous aspergillosis and invasive aspergillosis. Primary cutaneous aspergillosis in a newborn presents as multiple papules or plaques, pustules or small abscesses, or crusted lesions. In a newborn, they commonly begin on the back. Pertinent associations included antibiotic use, corticosteroid use, and hospital construction, skin maceration from adhesive tape and from an ox meter sensor. In this review, 54% of the cases of primary cutaneous aspergillosis were cured with antifungal, medication with or without surgical debridement. Disseminated invasive aspergillosis was associated with antibiotic and corticosteroid use. Respiratory distress, hepatic failure, seizures, and skin papules were clinical features commonly found in invasive aspergillosis. Unlike primary cutaneous aspergillosis, all newborns with disseminated invasive aspergillosis died secondary to their infection. Groll concluded that the outcome of primary cutaneous aspergillosis was favorable and that of disseminated invasive aspergillosis was poor.
Invasion and dissemination is a common sequel of cutaneous or respiratory infection. Aspergillus species have a propensity to invade blood vessels, causing local hemorrhage and thrombosis. The organism may disseminate from the bloodstream to deeper organs, including invasion of tissues such as the lungs, muscles, ribs, pericardium, or pleurae. 13 We believe our patient had disseminated aspergillosis based on coagulopathy, hepatomegaly, and the appearance of new lesions at distant sites.
Diagnosing aspergillosis is challenging. Aspergillus is usually transmitted by airborne spores, thus evading surveillance. In contrast to other fungal infections such as candidiasis, fungal blood cultures for Aspergillus are negative in 75% of the cases. By the time infection with Aspergillus is discovered, it may be disseminated and difficult to cure, particularly in immunocompromised patients. Tissue biopsy with special stains and tissue culture are the preferred methods for diagnosing aspergillosis. Biopsies may be taken from cutaneous or pulmonary lesions. Advances in computed tomography and polymerase chain reaction (PCR) technology may help to diagnose patients at risk for Aspergillus earlier. High-resolution computed tomography can diagnose pulmonary lesions in neutropenic patients. Using PCR, Aspergillus DNA detected in serum can diagnose invasive aspergillosis at an early stage. 14 We could not prove definitively that our patient had disseminated aspergillosis without an autopsy. Both the abdominal ultrasound and a post-mortem MRI failed to show fungal abscesses. However, in the case of disseminated fungal disease seen in the immune compromised, fungal abscesses of solid organs develop. These deep fungal infections are microabscesses and can be difficult to detect by ultrasound [15] . The combination of ultrasound and computed tomography with contrast is recommended to optimize diagnosis, however, both modalities may be negative even in patients ultimately found to have disseminated fungal disease at autopsy [16] . We suspect but cannot confirm disseminated aspergillosis based on the coagulopathy, hepatomegaly, and the appearance of new lesions while on antifungal therapy.
The treatment of choice for aspergillosis in the neonate remains amphotericin B. However, amphotericin B is associated with significant toxicity, and treatment failures, especially with disseminated Aspergillus infections, are common. In our patient, despite receiving systemic antifungal therapy with fluconazole and amphotericin B for 7 days prior to the development of cutaneous aspergillosis, clinical deterioration was progressive during the 6 days from the onset of the cutaneous lesion until support was discontinued. The patient received antifungal therapy until death.
In recent years there has been a major effort to develop new antifungal agents with activity against Aspergillus species. The options available today include lipid preparations of amphotericin B. These preparations allow higher doses of amphotericin B to be delivered and are associated with less renal toxicity. 15 The efficacy of liposomal preparations of amphotericin B, is comparable to amphotericin B, and some studies indicate there may be improved outcomes in patients with aspergillosis. 16 There is limited information on the use of liposomal preparations of amphotericin B in children. In addition to amphotericin B, two new antifungal agents with efficacy against Aspergillus species have become available recently. These include the echinocandin lipopeptide caspofungin and the triazole voriconazole. These agents show promise in the treatment of aspergillosis refractory to conventional therapy; however there are no data on the use of these agents in Figure 3 . Purpura and ulceration were biopsied on this infant. Biopsy was consistent with a thermal burn. Bacterial and fungal cultures were negative. the neonate. 17, 18 Surgical therapy may be an important adjunct for the treatment of localized Aspergillus infection. 12 However, infants, especially preterm infants, may not tolerate surgical resection, especially if cutaneous lesions are extensive.
Outbreaks of infections with Aspergillus in immuno-compromised patients have been linked to hospital construction. 22, 23 Hospital renovation may be the setting in which infection with Aspergillus flavus developed in our patient, with the airborne spread of dust and spores leading to colonization and subsequent infection. However, this theory was not confirmed by epidemiologic studies performed in the nursery. Filtration systems have become a deterrent against airborne transmission of Aspergillus. 24 Rooms equipped with HEPA filters are associated with a virtual absence of fungal contamination compared to rooms not equipped with HEPA filters.
1 Sensible strategies that providers can undertake to prevent cutaneous aspergillosis include modification of the environment, identification of patients at risk, early biopsy of suspicious lesions, and adherence to infection control protocols.
